Brief Information of the Cell Line and Protein
Cell Line ID: CL000351 , Dede
Synonyms
DeDe
DEDE
Category Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Cellosaurus ID
CVCL_2886
Protein ID: PT01505 , Somatostatin receptor type 2
Gene Name SSTR2
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P30874
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000351  Protein ID: PT01505
 
Compound ID Compound Name Compound Formula
CP0847825
Radiolabeled octreotide derivative
   Show/Hide
C49H65IN10O11S2
 1
1
IC50 = 0.47 nM
   TI
   LI
   LO
   TS
CP0049566
15-28-Somatostatin-28
   Show/Hide
C76H104N18O19S2
 2
1
IC50 = 0.67 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.7 nM
   TI
   LI
   LO
   TS
CP0851109
(5S)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-({[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]carbonyl}amino)-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C40H45F3N8O6
 1
1
IC50 = 0.73 nM
   TI
   LI
   LO
   TS
CP0380894
(4R,7S,10S,13S,16S,19R,22S,25S,28R)-16-(4-aminobutyl)-10,22,25-tribenzyl-28-[[(2S)-5-carbamimidamido-2-[[2-[2-[2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]ethoxy]ethoxy]acetyl]amino]pentanoyl]amino]-13-[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-19-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carboxylic acid
   Show/Hide
C85H120N20O23S2
 1
1
IC50 = 0.76 nM
   TI
   LI
   LO
   TS
CP0860572
Radiolabeled octreotide derivative
   Show/Hide
C61H83IN10O22S2
 1
1
IC50 = 0.78 nM
   TI
   LI
   LO
   TS
CP0844992
Radiolabeled octreotide derivative
   Show/Hide
C67H93IN10O27S2
 1
1
IC50 = 0.95 nM
   TI
   LI
   LO
   TS
CP0387937
(4R,7S,10S,13S,16S,19R,22S,25S,28R)-16-(4-aminobutyl)-10,22,25-tribenzyl-13-[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-19-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27-octaoxo-28-[[2-[[2-[2-[2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]ethoxy]ethoxy]acetyl]amino]acetyl]amino]-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carboxylic acid
   Show/Hide
C81H111N17O23S2
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0847824
Radiolabeled octreotide derivative
   Show/Hide
C67H95IN10O26S2
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0381553
SRIF-D-Trp8
   Show/Hide
C76H104N18O19S2
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0899676
Radiolabeled octreotide derivative
   Show/Hide
C61H85IN10O21S2
 1
1
IC50 = 1.2 nM
   TI
   LI
   LO
   TS
CP0395143
(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[(2R)-3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid
   Show/Hide
C65H90N14O19S2
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0431775
(4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-37-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C92H130N22O26S2
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0847877
Radiolabeled octreotide derivative
   Show/Hide
C49H65IN10O11S2
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0480255
(4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(naphthalen-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C78H105N17O19S2
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0421490
(4S,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-19-(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-34-(3-carbamimidamidopropyl)-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-37-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C92H130N24O26S2
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0042009
(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
   Show/Hide
C49H65N11O10S2
 1
1
IC50 = 1.9 nM
   TI
   LI
   LO
   TS
CP0050675
(4R,7R,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-{2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]hexanamido]propanamido]a
   Show/Hide
C137H207N41O39S3
 4
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
2
IC50 = 2.4 nM
   TI
   LI
   LO
   TS
3
IC50 = 2.6 nM
   TI
   LI
   LO
   TS
4
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0844993
Radiolabeled octreotide derivative
   Show/Hide
C58H77IN10O18S3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0847861
Radiolabeled octreotide derivative
   Show/Hide
C58H77IN10O18S3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0913773
Radiolabeled octreotide derivative
   Show/Hide
C55H73IN10O17S2
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0880681
(5S)-6-(benzylamino)-5-((4R)-4-(2,3-dihydrospiro[indene-1,4'-piperidine]-1'-ylcarboxamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H47F3N6O5
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0894372
(5S)-5-[(4R)-4-{[(1-benzoylpiperidin-4-yl)carbonyl]amino}-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C40H45F3N6O6
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0038580
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1S)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C137H207N41O39S3
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0854295
Radiolabeled octreotide derivative
   Show/Hide
C55H75IN10O16S2
 1
1
IC50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0158449
(3S,6S,9S,12S,15R,18S,21S,24R)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclotetracosane-3-carboxylic acid
   Show/Hide
C54H64N10O11S2
 1
1
IC50 = 3.9 nM
   TI
   LI
   LO
   TS
CP0459767
(4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-[(4-hydroxyphenyl)methyl]-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C74H103N17O20S2
 1
1
IC50 = 4.1 nM
   TI
   LI
   LO
   TS
CP0851108
(5S)-6-(benzylamino)-6-oxo-5-((4R)-3-oxo-4-(4-(phenylsulfonyl)piperazine-1-carboxamido)-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexan-1-aminium trifluoroacetate
   Show/Hide
C38H44F3N7O7S
 1
1
IC50 = 4.2 nM
   TI
   LI
   LO
   TS
CP0251255
(3S,6S,9S,12S,15R,18S,21S,24S)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclopentacosane-3-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 4.8 nM
   TI
   LI
   LO
   TS
CP0436365
(5R,8S,11S,14R,17S,20R)-11-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-20-[[(2R)-2-amino-3-phenylpropanoyl]amino]-17-benzyl-8-[(1R)-1-hydroxyethyl]-14-(1H-indol-3-ylmethyl)-7,10,13,16,19-pentaoxo-1,2-dithia-6,9,12,15,18-pentazacyclodocosane-5-carboxamide
   Show/Hide
C51H69N11O10S2
 1
1
IC50 = 4.9 nM
   TI
   LI
   LO
   TS
CP0153525
(4S,7S,10S,13S,16R,19S,22S,25R)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C56H68N10O11S2
 1
1
IC50 = 4.9 nM
   TI
   LI
   LO
   TS
CP0146015
(3S,6S,9S,12S,15R,18S,21S,24R)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclopentacosane-3-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 5.4 nM
   TI
   LI
   LO
   TS
CP0431909
4-[(2R)-2-amino-3-[[(4R,7S,10S,13R,16S,19S)-10-(4-aminobutyl)-4-[[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-oxopropyl]-1H-pyrrole-2-carboxylic acid
   Show/Hide
C57H68N12O12S2
 1
1
IC50 = 5.7 nM
   TI
   LI
   LO
   TS
CP0251254
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cycloheptacosane-4-carboxylic acid
   Show/Hide
C57H70N10O11S2
 1
1
IC50 = 6.5 nM
   TI
   LI
   LO
   TS
CP0158450
(4R,7S,10S,13S,16R,19S,22S,25S)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C56H68N10O11S2
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0251256
(4S,7S,10S,13S,16R,19S,22S,25S)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C56H68N10O11S2
 1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0473247
(2S,5R,8S,11S,14S,19S,Z)-5-((1H-indol-2-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-8-(4-aminobutyl)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-11-((R)-1-hydroxyethyl)-2-(naphthalen-1-ylmethyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentaazacycloicos-16-ene-14-carboxamide
   Show/Hide
C55H70N10O10
 1
1
IC50 = 9.6 nM
   TI
   LI
   LO
   TS
CP0910410
(5S)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-[(3-phenylpropanoyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0137483
(4S,7S,10S,13S,16R,19S,22S,25S)-25-Amino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C54H66N10O10S2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0262548
(4S,7S,10S,13S,16R,19S,22S,25R)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclopentacosane-4-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0387933
2-[[(2S)-2-[[(4R,7S,10S,13S,16R,19S,22S,25R)-13-(4-aminobutyl)-25-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]-3-hydroxypropanoyl]amino]acetic acid
   Show/Hide
C92H131N21O24S2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0894371
(5S)-6-(benzylamino)-5-[(4R)-4-[(1,1'-biphenyl-4-ylcarbonyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C40H40F3N5O5
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0137479
(4S,7S,10S,13S,16R,19S,22S,25S)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclopentacosane-4-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0160828
(3S,6S,9S,12S,15R,18S,21S,24S)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclotetracosane-3-carboxylic acid
   Show/Hide
C54H64N10O11S2
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0395163
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
   Show/Hide
C65H92N14O18S2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0160829
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C54H66N10O10S2
 1
1
IC50 = 14.5 nM
   TI
   LI
   LO
   TS
CP0452358
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(naphthalen-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C78H105N17O19S2
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0251257
(4S,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C54H66N10O10S2
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0153218
(3R,6S,9S,12S,15R,18S,21S,24S)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclopentacosane-3-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 18.5 nM
   TI
   LI
   LO
   TS
CP0907338
(5S)-6-(benzylamino)-5-[(4R)-4-[(4-chlorobenzoyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C34H35ClF3N5O5
 1
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
CP0137482
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclopentacosane-4-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0192734
(3R,6S,9S,12S,15R,18S,21S,24R)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclotetracosane-3-carboxylic acid
   Show/Hide
C54H64N10O11S2
 1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0387793
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-[(4-hydroxyphenyl)methyl]-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C74H103N17O20S2
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0160827
(4R,7S,10S,13S,16R,19S,22S,25S)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cycloheptacosane-4-carboxylic acid
   Show/Hide
C57H70N10O11S2
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0036365
H-c(Cys3-Phe6-Phe7-DTrp8-Lys9-Thr10-Phe11-Cys14)-OH
   Show/Hide
C54H66N10O10S2
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0350110
(3R,6S,9S,12S,15R,18S,21S,24R)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclopentacosane-3-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0360266
(4R,7S,10S,13S,16R,19S,22S,25S)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclopentacosane-4-carboxylic acid
   Show/Hide
C55H66N10O11S2
 1
1
IC50 = 42 nM
   TI
   LI
   LO
   TS
CP0479259
(2S,5R,8S,11S,14S,19S,Z)-5-((1H-indol-2-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-8-(4-aminobutyl)-2-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-11-((R)-1-hydroxyethyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentaazacycloicos-16-ene-14-carboxamide
   Show/Hide
C51H68N10O10
 1
1
IC50 = 44 nM
   TI
   LI
   LO
   TS
CP0372376
4-(((3S,6S,9R,12S,15S,20S,Z)-9-((1H-indol-2-yl)methyl)-15-((R)-2-amino-3-phenylpropanamido)-6-(4-aminobutyl)-12-benzyl-20-((2R,3R)-1,3-dihydroxybutan-2-ylcarbamoyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacycloicos-17-en-3-yl)methyl)phenyl benzoate
   Show/Hide
C63H74N10O11
 1
1
IC50 = 46 nM
   TI
   LI
   LO
   TS
CP0158451
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Acetylamino-13-(4-amino-butyl)-7,19,22-tribenzyl-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid
   Show/Hide
C56H68N10O11S2
 1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS
CP0431784
2-[[(2S)-2-[[(4R,7S,10S,13S,16R,19S,22S,25S)-13-(4-aminobutyl)-25-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]-3-hydroxypropanoyl]amino]acetic acid
   Show/Hide
C92H131N21O24S2
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0852832
(S)-6-amino-N-benzyl-2-((R)-3-oxo-4-(2-phenylacetamido)-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexanamide 2,2,2-trifluoroacetate
   Show/Hide
C35H38F3N5O5
 1
1
IC50 = 83 nM
   TI
   LI
   LO
   TS
CP0372651
(2S,5R,8S,11S,14S,19S,Z)-5-((1H-indol-2-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-8-(4-aminobutyl)-2-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-11-(4-hydroxybenzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentaazacycloicos-16-ene-14-carboxamide
   Show/Hide
C56H70N10O10
 1
1
IC50 = 87 nM
   TI
   LI
   LO
   TS
CP0387648
4-(((3S,6S,9R,12S,15S,20S,Z)-9-((1H-indol-2-yl)methyl)-15-((R)-2-amino-3-phenylpropanamido)-6-(4-aminobutyl)-20-((2R,3R)-1,3-dihydroxybutan-2-ylcarbamoyl)-12-(naphthalen-1-ylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacycloicos-17-en-3-yl)methyl)phenyl benzoate
   Show/Hide
C67H76N10O11
 1
1
IC50 = 101 nM
   TI
   LI
   LO
   TS
CP0852833
(5S)-5-[(4R)-4-(benzoylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C34H36F3N5O5
 1
1
IC50 = 103 nM
   TI
   LI
   LO
   TS
CP0907350
(S)-6-amino-N-benzyl-2-((R)-4-(3,3-diphenylpropanamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexanamide 2,2,2-trifluoroacetate
   Show/Hide
C42H44F3N5O5
 1
1
IC50 = 103 nM
   TI
   LI
   LO
   TS
CP0435939
(4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-22-[(1-benzylimidazol-4-yl)methyl]-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C78H107N19O19S2
 1
1
IC50 = 106 nM
   TI
   LI
   LO
   TS
CP0192735
(3R,6S,9S,12S,15R,18S,21S,24S)-24-Acetylamino-12-(4-amino-butyl)-6,18,21-tribenzyl-9-((R)-1-hydroxy-ethyl)-15-(1H-indol-3-ylmethyl)-5,8,11,14,17,20,23-heptaoxo-1,2-dithia-4,7,10,13,16,19,22-heptaaza-cyclotetracosane-3-carboxylic acid
   Show/Hide
C54H64N10O11S2
 1
1
IC50 = 109 nM
   TI
   LI
   LO
   TS
CP0046225
(4R,7S,10S,13S,16S,19S,22S,25R)-25-amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid
   Show/Hide
C54H66N10O10S2
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0459766
(4R,7S,10S,13S,16R,19S,22S,25R)-25-amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(naphthalen-2-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid
   Show/Hide
C56H67N9O10S2
 1
1
IC50 = 173 nM
   TI
   LI
   LO
   TS
CP0851107
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-[(2-phenylethyl)amino]hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 183 nM
   TI
   LI
   LO
   TS
CP0891468
(5S)-6-[(1-naphthylmethyl)amino]-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C39H40F3N5O5
 1
1
IC50 = 215 nM
   TI
   LI
   LO
   TS
CP0914902
(5S)-6-(benzylamino)-5-[(4R)-4-[(diphenylacetyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H42F3N5O5
 1
1
IC50 = 242 nM
   TI
   LI
   LO
   TS
CP0422746
4-[(2R)-2-amino-3-[[(5R,8S,11S,14R,17S,20S)-11-(4-aminobutyl)-5-[[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]-8-[(1R)-1-hydroxyethyl]-17-[(4-hydroxyphenyl)methyl]-14-(1H-indol-3-ylmethyl)-7,10,13,16,19-pentaoxo-1,2-dithia-6,9,12,15,18-pentazacyclodocos-20-yl]amino]-3-oxopropyl]-1H-pyrrole-2-carboxylic acid
   Show/Hide
C59H72N12O12S2
 1
1
IC50 = 267 nM
   TI
   LI
   LO
   TS
CP0891469
(5S)-6-methoxy-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C29H33F3N4O6
 1
1
IC50 = 290 nM
   TI
   LI
   LO
   TS
CP0869974
(5S)-5-[(4R)-4-(acetylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C29H34F3N5O5
 1
1
IC50 = 292 nM
   TI
   LI
   LO
   TS
CP0852834
(5S)-6-(benzylamino)-5-((4R)-4-(1-(methylsulfonyl)spiro[indoline-3,4'-piperidine]-1'-ylcarboxamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H48F3N7O7S
 1
1
IC50 = 327 nM
   TI
   LI
   LO
   TS
CP0434974
(3R,6S,9S,12R,15S,18R)-9-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-18-[[(2R)-2-amino-3-phenylpropanoyl]amino]-15-benzyl-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-5,8,11,14,17-pentaoxo-1,2-dithia-4,7,10,13,16-pentazacyclooctadecane-3-carboxamide
   Show/Hide
C47H61N11O10S2
 1
1
IC50 = 337 nM
   TI
   LI
   LO
   TS
CP0387735
(2S,5R,8S,11S,14S,19S,E)-5-((1H-indol-2-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-8-(4-aminobutyl)-2-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-11-(4-hydroxybenzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentaazacycloicos-16-ene-14-carboxamide
   Show/Hide
C56H70N10O10
 1
1
IC50 = 355.5 nM
   TI
   LI
   LO
   TS
CP0852838
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-{[(1S)-1-phenylethyl]amino}hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 452 nM
   TI
   LI
   LO
   TS
CP0880682
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-{[(1R)-1-phenylethyl]amino}hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0380893
2-[[(2S)-2-[[(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-19-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]acetic acid
   Show/Hide
C82H126N22O27S2
 1
1
IC50 = 946 nM
   TI
   LI
   LO
   TS
CP0852836
(5R)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C35H38F3N5O5
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0852837
(5S)-5-[(4R)-4-(acetylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxo-6-[(2-phenylethyl)amino]hexan-1-aminium trifluoroacetate
   Show/Hide
C30H36F3N5O5
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0417051
4-(((3S,6S,9R,12S,15S,20S,E)-9-((1H-indol-2-yl)methyl)-15-((R)-2-amino-3-phenylpropanamido)-6-(4-aminobutyl)-12-benzyl-20-((2R,3R)-1,3-dihydroxybutan-2-ylcarbamoyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacycloicos-17-en-3-yl)methyl)phenyl benzoate
   Show/Hide
C63H74N10O11
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0435954
(4R,7S,10S,13S,16R,19S,22S,25R)-25-amino-13-(4-aminobutyl)-7,19,22-tribenzyl-16-[(1-benzylimidazol-4-yl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid
   Show/Hide
C56H69N11O10S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0459765
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-22-[(1-benzylimidazol-4-yl)methyl]-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
   Show/Hide
C78H107N19O19S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0494320
(4R,7S,10S,13S,16S,19S,22S,25R)-25-amino-13-(4-aminobutyl)-7,19,22-tribenzyl-16-[(1-benzylimidazol-4-yl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid
   Show/Hide
C56H69N11O10S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0387935
2-[[(2S)-2-[[(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-19-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-10-(4-aminobutyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]acetic acid
   Show/Hide
C82H126N22O26S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS